Pietrantonio F, Lobefaro R, Antista M, Miceli R, et al. A randomized, multicenter, phase 2 trial comparing CAPTEM versus FOLFIRI as
second-line treatment for MGMT-methylated, RAS-mutated metastatic colorectal
cancer patients. Ann Oncol 2019;30 Suppl 4:iv135.
PMID: 32085043